Two Sigma Advisers’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-38,071
| Closed | -$172K | – | 2333 |
|
|
2025
Q3 | $172K | Buy |
38,071
+27,390
| +256% | +$80.7K | ﹤0.01% | 2161 |
|
|
2025
Q2 | $23K | Buy |
+10,681
| New | +$29.9K | ﹤0.01% | 2288 |
|
|
2024
Q3 | – | Sell |
-22,901
| Closed | -$157K | – | 2267 |
|
|
2024
Q2 | $157K | Buy |
22,901
+6,731
| +42% | +$62.6K | ﹤0.01% | 2257 |
|
|
2024
Q1 | $229K | Sell |
16,170
-30,060
| -65% | -$457K | ﹤0.01% | 2171 |
|
|
2023
Q4 | $348K | Sell |
46,230
-3,040
| -6% | -$27.7K | ﹤0.01% | 2057 |
|
|
2023
Q3 | $739K | Buy |
49,270
+6,550
| +15% | +$118K | ﹤0.01% | 1650 |
|
|
2023
Q2 | $679K | Sell |
42,720
-24,879
| -37% | -$262K | ﹤0.01% | 1696 |
|
|
2023
Q1 | $485K | Sell |
67,599
-5,471
| -7% | -$38.7K | ﹤0.01% | 1959 |
|
|
2022
Q4 | $423K | Sell |
73,070
-32,110
| -31% | -$243K | ﹤0.01% | 1945 |
|
|
2022
Q3 | $999K | Sell |
105,180
-45,280
| -30% | -$595K | ﹤0.01% | 1518 |
|
|
2022
Q2 | $1.81M | Buy |
150,460
+130
| +0.1% | +$1.36K | 0.01% | 1271 |
|
|
2022
Q1 | $1.97M | Sell |
150,330
-39,650
| -21% | -$580K | 0.01% | 1266 |
|
|
2021
Q4 | $3.34M | Buy |
189,980
+13,290
| +8% | +$266K | 0.01% | 948 |
|
|
2021
Q3 | $3.83M | Buy |
176,690
+79,170
| +81% | +$2.02M | 0.01% | 912 |
|
|
2021
Q2 | $3.41M | Buy |
97,520
+8,030
| +9% | +$433K | 0.01% | 1042 |
|
|
2021
Q1 | $8.82M | Sell |
89,490
-3,680
| -4% | -$442K | 0.02% | 630 |
|
|
2020
Q4 | $10.1M | Buy |
93,170
+1,350
| +1% | +$167K | 0.03% | 561 |
|
|
2020
Q3 | $9.46M | Buy |
91,820
+90,660
| +7,816% | +$13.6M | 0.03% | 546 |
|
|
2020
Q2 | $242K | Sell |
1,160
-540
| -32% | -$95.6K | ﹤0.01% | 2192 |
|
|
2020
Q1 | $166K | Sell |
1,700
-110
| -6% | -$12.8K | ﹤0.01% | 2215 |
|
|
2019
Q4 | $209K | Buy |
+1,810
| New | +$160K | ﹤0.01% | 2173 |
|
|
2019
Q3 | – | Sell |
-7,540
| Closed | -$897K | – | 2203 |
|
|
2019
Q2 | $897K | Sell |
7,540
-7,450
| -50% | -$616K | ﹤0.01% | 1573 |
|
|
2019
Q1 | $785K | Sell |
14,990
-8,300
| -36% | -$336K | ﹤0.01% | 1621 |
|
|
2018
Q4 | $734K | Buy |
23,290
+1,920
| +9% | +$78.1K | ﹤0.01% | 1626 |
|
|
2018
Q3 | $1.29M | Sell |
21,370
-710
| -3% | -$39.9K | ﹤0.01% | 1408 |
|
|
2018
Q2 | $1.17M | Buy |
22,080
+9,310
| +73% | +$560K | ﹤0.01% | 1544 |
|
|
2018
Q1 | $741K | Buy |
12,770
+6,020
| +89% | +$375K | ﹤0.01% | 1667 |
|
|
2017
Q4 | $236K | Buy |
+6,750
| New | +$222K | ﹤0.01% | 2030 |
|
|
2016
Q3 | – | Sell |
-4,420
| Closed | -$140K | – | 2193 |
|
|
2016
Q2 | $140K | Buy |
4,420
+1,470
| +50% | +$66.4K | ﹤0.01% | 1931 |
|
|
2016
Q1 | $153K | Buy |
2,950
+1,460
| +98% | +$81.5K | ﹤0.01% | 1880 |
|
|
2015
Q4 | $142K | Sell |
1,490
-340
| -19% | -$29.9K | ﹤0.01% | 1733 |
|
|
2015
Q3 | $158K | Buy |
+1,830
| New | +$234K | ﹤0.01% | 1680 |
|
Two Sigma Advisers's ADVM Position: Q4 2025 in Review
Two Sigma Advisers sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 38,071 shares — an estimated $172K sold.
Two Sigma Advisers first reported a position in ADVM in Q3 2015 and held it in 32 quarters. The position peaked at $10.1M in Q4 2020. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.
- Two Sigma Advisers reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
- Two Sigma Advisers sold 38,071 Adverum Biotechnologies shares in Q4 2025, an estimated $172K.
- Two Sigma Advisers first reported a position in Adverum Biotechnologies in Q3 2015 and held it in 32 quarters.
- Two Sigma Advisers's Adverum Biotechnologies position peaked at $10.1M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.
Based on Two Sigma Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.